Prostate Cancer Trials

This is a randomized phase 2 study of mitoxantrone vs. mitoxantrone with cetuximab in metastatic androgen independent prostate cancer (AIPC) previously treated with docetaxel-based chemotherapy.

For additional information about Highline's Cancer Care Program, call (206) 439-5577.